Randy Scott
CEO
GL
Genomic Life
The startup provides genomic profiling services that enable individuals to assess their genetic predisposition to diseases, particularly cancer, through advanced DNA sequencing and analysis. By identifying genetic risks early, the company facilitates timely interventions and personalized treatment strategies based on individual genetic profiles.
- Biotechnology
- Digital Health
- Software Only
Updated 6 months ago
Funding
Raised to date
$44.4MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Problem
Individuals often lack sufficient awareness and access to personalized guidance regarding their genetic predispositions to diseases, particularly cancer and cardiovascular conditions. This lack of awareness can lead to delayed preventative measures and less effective treatment strategies.
Solution
Genomic Life provides personalized health guidance and navigation services, leveraging genomic insights to facilitate early disease detection and proactive health management. The company offers access to a curated marketplace of genetic screenings, including tests for hereditary cancer syndromes, cardiovascular diseases, and pharmacogenomic compatibility. Genomic Life's services include expert cancer navigation, personalized action plans, and ongoing support from navigators and genetic counselors, ensuring individuals and their healthcare providers can make informed decisions based on genetic risks and recommended next steps. By integrating genomic data with personalized support, Genomic Life aims to improve health outcomes and reduce the burden of disease.
Target Audience
Genomic Life serves both individuals seeking personalized health insights and organizations, including employers, TPAs, and insurers, aiming to enhance the health and well-being of their employees and members.
Features
- Access to a curated marketplace of top-tier genetic screening tests for cancer, cardiovascular disease, and other medically actionable disorders.
- Pharmacogenomic testing to evaluate individual responses to medications and reduce the risk of adverse drug reactions.
- Carrier screening for family planning, assessing the risk of transmitting genetic disorders to future generations.
- Personalized cancer navigation services, providing guidance and support throughout prevention, screening, diagnosis, treatment, and survivorship.
- Actionable reports detailing genetic risks and recommended next steps, accessible through a secure online member portal.
- Ongoing support from trained navigators, genetic counselors, and pharmacists.
- Integration with existing employee benefits programs to complement medical, prescription, and critical illness plans.